CHMX.US NEXT-ChemX Corporation
- Market cap
- USD 285K
- P/E
- -
- P/B
- 283.83x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2025.
Is CHMX.US undervalued?
Graham numberThe Graham number of NEXT-ChemX Corporation cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
NEXT-ChemX Corporation fundamental analysis
No fundamental analysis for NEXT-ChemX Corporation yet.
NEXT-ChemX Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About NEXT-ChemX Corporation
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NE…
Full company profileNEXT-ChemX Corporation financial statements
2025 annualized: Fiscal year 2025 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2025, the balance sheet is the latest quarter. Figures change when the annual report is published.
NEXT-ChemX Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 1.50K | 0.00 | 14.7K | 2.37K | 633K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | - | 1.50K | - | 14.7K | 2.37K | 487K | -353K | -5.16K | -5.34K | -155K | -703K |
| Operating Income | -773.00 | -37.4K | -33.3K | -77.1K | -176K | -118K | -1.77M | -1.67M | -1.98M | -1.74M | -1.61M |
| EBITDA | -773.00 | -37.0K | -33.3K | -70.7K | -176K | -118K | -1.41M | -1.67M | -2.27M | -1.58M | -1.42M |
| Net Income | -773.00 | -37.4K | -33.3K | -70.7K | -140K | 345K | -1.78M | -1.74M | -2.36M | -1.81M | -1.84M |
| EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 | 0.04 | -0.08 | -0.06 | -0.08 | -0.06 | -0.06 |
| Balance Sheet | |||||||||||
| Total Assets | 6.08K | 6.87K | 13.2K | 83.9K | 515K | 46.8K | 3.18M | 3.22M | 3.30M | 3.25M | 3.17M |
| Total Liabilities | 1.53K | 13.5K | 43.4K | 80.1K | 667K | 201K | 1.47M | 2.49M | 3.93M | 6.16M | 6.99M |
| Shareholders' Equity | 4.55K | -6.65K | -30.3K | 20.5K | -98.6K | -154K | 1.71M | 732K | -629K | -2.90M | -3.82M |
| Cash & Short-term Investments | 6.08K | 207.00 | 6.50K | 69.2K | 418K | 44.6K | 10.4K | 28.4K | 67.4K | 101K | 63.0K |
| Total Debt | 1.53K | 9.63K | 41.7K | 2.91K | 2.87K | - | 693K | 926K | 945K | 2.43M | 2.93M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -773.00 | -40.2K | -35.4K | -34.5K | 377K | 183K | -704K | -935K | -545K | -1.53M | -1.07M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 24.1K | 24.1K | 24.1K | 24.1K | 1.58K | 0.00 | 0.00 | 19.40 |
| Free Cash Flow | -773.00 | -40.2K | -35.4K | -34.5K | 377K | 183K | -728K | -937K | -545K | -1.53M | -1.07M |
| Ratios | |||||||||||
| ROE | -17.0% | - | - | -344.0% | - | - | -104.2% | -238.3% | - | - | - |
| ROA | -12.7% | -544.0% | -252.7% | -84.2% | -27.2% | 737.9% | -56.0% | -54.2% | -71.5% | -55.7% | -58.1% |
| Net Profit Margin | - | -2,493.1% | - | -481.0% | -5,931.3% | 54.5% | - | - | - | - | - |
| Debt to Equity | 0.34x | - | - | 0.14x | - | - | 0.40x | 1.27x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
NEXT-ChemX Corporation dividends
NEXT-ChemX Corporation has not paid dividends in the last 9 fiscal years.
Who owns NEXT-ChemX Corporation
- Insiders 90.09%
- Institutions 0.00%
- Public & others 9.91%
- Shares outstanding 28.5M
- Free float 26.7M
NEXT-ChemX Corporation company profile
- Company name
- NEXT-ChemX Corporation
- Ticker
- CHMX.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Professional Services
- Employees
- 5
- Fiscal year end
- December
- Address
- 1980 Festival Plaza Drive, Las Vegas, NV, United States, 89135
- Phone
- 725 867 0789
- Website
- next-chemx.com
About NEXT-ChemX Corporation
NEXT-ChemX Corporation owns ion targeting membrane extraction technology in the United States. The company's technology mimics nature biophysical processes enabling the technology to extract ions from a liquid solution at ambient temperatures and pressures. Its technology is designated as NCX and applied for lithium extraction, vegetable oil refining, radioactive ion extraction, and desalination. The company was formerly known as AllyMe Group, Inc. and changed its name to NEXT-ChemX Corporation in July 2021. NEXT-ChemX Corporation was incorporated in 2014 and is headquartered in Las Vegas, Nevada. NEXT-ChemX Corporation operates as a subsidiary of NEXT-ChemX Texas.
NEXT-ChemX Corporation management
4- Mr. John Michael JohnsonFounder, CFO, President, Treasurer & Director · born 1966
- Dr. Nikolai M. Kocherginsky Ph.D.Founder & Chief Scientist
- Mr. Dmitry SindalovskyFounder and VP Technology Coordination & Business Development
- Mr. Dominic J. MajendieConsultant · born 1962